Retinal changes and cardiac remodelling in systemic hypertension. - Wikidata - awgldk - TriplyDB

Retinal changes and cardiac remodelling in systemic hypertension.

Retinal changes and cardiac remodelling in systemic hypertension.

http://www.wikidata.org/entity/Q37487219

about

Retinal vascular changes in hypertensive patients in Ibadan, Sub-Saharan Africa.How does hypertension affect your eyes?The association of severity of retinal vascular changes and cardiac remodelling in systemic hypertension.

P2860

Q37170512-6FCBF2C4-B82E-4A5A-A2B2-33B7A50B4E19 Q37867491-B9D0DD2E-FE1E-4962-80DD-E8D995F6C139 Q40909018-76C62AB3-EA5E-45D9-A8EA-A9C4DC02CBB1

P2860

Retinal changes and cardiac remodelling in systemic hypertension.

http://www.wikidata.org/entity/Q37487219

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Retinal changes and cardiac remodelling in systemic hypertension.

@en

Retinal changes and cardiac remodelling in systemic hypertension.

@nl

type

label

Retinal changes and cardiac remodelling in systemic hypertension.

@en

Retinal changes and cardiac remodelling in systemic hypertension.

@nl

prefLabel

Retinal changes and cardiac remodelling in systemic hypertension.

@en

Retinal changes and cardiac remodelling in systemic hypertension.

@nl

P1433

Q37487219-1F608138-8F12-47BF-95DA-B5664E8B6796

P1476

Q37487219-A1479E20-B408-475F-871C-0CB3C455028E

P2093

Q37487219-0CD7913B-8D44-43EA-A1B2-D8B0AB45234C

Q37487219-E54C203E-7706-4EB5-8BC4-A40357A146DA

Q37487219-E6134493-A427-4B9B-8FB7-9F5ABE45B822

Q37487219-FC3696A6-B46F-4B1D-B446-8C38F0354105

P2860

Q37487219-00E7472A-9C9A-4BAE-86F2-2DF5DC263670

Q37487219-03512665-E74E-4D4D-B847-E70939BE9B89

Q37487219-03C19306-B5AB-4119-841C-E8FF390DDBAB

Q37487219-0689860C-144C-4F2B-88A7-58207689EA82

Q37487219-0C8FA4FF-78D7-4ADA-8EA7-7ABD1D01B8A6

Q37487219-1BDD4513-096E-4C06-AFA8-0A8863B66B18

Q37487219-22FB878D-79CA-4C65-8CD7-B7E277F7DCD5

Q37487219-4E32DEF4-9D3F-4A9B-AA54-5D8B162903B9

Q37487219-56AA9424-1B1C-4FF2-A349-81FFBB4E35D0

Q37487219-646A4B75-3400-47E9-A607-A9DB439B5BBE

P304

Q37487219-75DE8F8C-6FD8-4F43-8110-3C14CF15C383

P31

Q37487219-9A685799-E712-49F5-BDF4-5AAA993C79C2

P356

Q37487219-C73EBBAC-F443-4547-AAD1-ED25250269C2

P433

Q37487219-5DE0A685-D032-4092-A3E4-9428EB585353

P478

Q37487219-2CE63F03-1E8D-4A09-9FBF-2E258B919FC7

P577

Q37487219-677B1899-765E-45D2-A70D-25815B246957

P698

Q37487219-B9AEEDD6-C3E2-4857-ADE9-597BE2DDFAEB

P921

Q37487219-13DD3F6D-0B0B-4187-9C44-3701488B911D

P356

1753944709103220

P1433

Therapeutic advances in cardiovascular disease

P1476

Retinal changes and cardiac remodelling in systemic hypertension.

@en

P2093

Carla Sala

http://www.w3.org/2001/XMLSchema#string

Cesare Cuspidi

http://www.w3.org/2001/XMLSchema#string

Francesca Negri

http://www.w3.org/2001/XMLSchema#string

Valentina Giudici

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Pressioni Arteriose Monitorate E Loro Associazioni.

Prognostic implications of left ventricular hypertrophy.

Essential hypertension.

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study.

Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment.

Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.

Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey.

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.

P304

205-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753944709103220

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19451180

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension